BioNexus Gene Lab Corp. Investment-related Liabilities
BioNexus Gene Lab Corp. (BGLC) had Investment-related Liabilities of $19.89 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:InvestmentRelatedLiabilities · last filed 2025-11-14
- 2025-09-30: Investment-related Liabilities $19.89K.
- 2025-06-30: Investment-related Liabilities $22.98K.
- 2025-03-31: Investment-related Liabilities $25.01K.
- 2024-12-31: Investment-related Liabilities $28.11K.
| Period end | Investment-related Liabilities |
|---|---|
| 2025-09-30 | $19.89K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $22.98K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $25.01K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $28.11K 10-Q · filed 2025-11-14 |
| 2023-12-31 | $21.99K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |